← Back to companies
Accent Therapeutics
1 open
Lexington, Massachusetts, United StatesFounded 201732+ employeesGrowth raisedGrowthPrivate
Last round: series c · $75M · Jan 2024(3 rounds total)
Founded by Robert A. Copeland
Backed by(13 investors)
EcoR1 CapitalThe Column GroupMirae Asset Capital Life ScienceBristol-Myers SquibbAtlas VentureNS InvestmentMirae Asset Venture InvestmentMirae Asset CapitalThe Mark Foundation for Cancer ResearchDroia VenturesAbbVieGoogle Ventures
Accent is leading the translation of RNA-modifying protein (RMP) biology into promising new therapies by combining a robust chemical biology platform with rigorous approaches to target identification and validation. Our seasoned team of drug developers is uniquely experienced to interrogate and advance small molecule therapies with far-reaching potential.
Open Positions at Accent Therapeutics (1 Jobs)
Ready to start your space career at Accent Therapeutics?
